Novartis has completed the spin-off of Sandoz‘s generics and biosimilars business, with the result that Sandoz Group debuted as an independent, publicly traded company. Sandoz shares were successfully listed on the Swiss stock exchange,
Tags :Djamila Batache
Bär & Karrer incorporates new professionals to the firm. Claudia Götz Staehelin (pictured left) and Oliver M. Brupbacher (pictured right) will join the firm as partners to reinforce the capabilities in the Basel
